Biotricity Inc. Reports Improved Financial Performance

Biotricity ( (BTCY) ) has released its Q1 earnings. Here is a breakdown of the information Biotricity presented to its investors.

Biotricity Inc. is a company operating in the healthcare sector, specializing in remote monitoring technologies for preventative care. It focuses on developing and commercializing a range of medical devices and technologies aimed at improving patient outcomes.

In its latest earnings report for the quarter ending June 30, 2025, Biotricity Inc. reported a revenue increase to $3.87 million, up from $3.20 million in the same quarter of the previous year. The company also reduced its net loss to $671,977 from $3.69 million, indicating an improvement in financial performance.

Key financial highlights include a gross profit of $3.12 million, an increase from $2.36 million in the previous year, and a reduction in operating expenses to $2.83 million from $3.48 million. Despite a net loss, the company showed progress in revenue growth and cost management, with technology fees contributing significantly to its revenue.

Looking ahead, Biotricity Inc. plans to continue its focus on revenue growth and improving liquidity through business development and additional financing. The company remains committed to investing in research and development to enhance its product offerings and expand its market presence.